W. Trepicchio

The therapeutic utility of Interleukin-11 in the treatment of inflammatory disease.

A. Dorner, W. Trepicchio, 1998, Expert opinion on investigational drugs.

Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production.

A. Dorner, M. Bozza, W. Trepicchio, 1996, Journal of immunology.

IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB.

A. Dorner, M. Bozza, W. Trepicchio, 1997, Journal of immunology.

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.

A. Dorner, J. Krueger, P. Gilleaudeau, 1999, The Journal of clinical investigation.

Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro.

M. Klempner, A. Dorner, M. Bozza, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells.

A. Dorner, M. Bozza, W. Trepicchio, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Hematopoietic, immunomodulatory and epithelial effects of interleukin-11

W. Trepicchio, K. Dykstra, U. Schwertschlag, 1999, Leukemia.

Developmental regulation of the human embryonic beta-like globin gene is mediated by synergistic interactions among multiple tissue- and stage-specific elements

M. Dyer, M. Baron, W. Trepicchio, 1993, Molecular and cellular biology.

A novel developmental regulatory motif required for stage-specific activation of the epsilon-globin gene and nuclear factor binding in embryonic erythroid cells

M. Dyer, M. Baron, W. Trepicchio, 1994, Molecular and cellular biology.

Upstream regulatory region of the human embryonic beta-like globin gene, epsilon.

R. Hardison, M. Dyer, M. Baron, 1994, DNA Sequence.